Ipatimup

RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH

Catarina Tavares

Name: Catarina Tavares

E-mail: ctavares@ipatimup.pt

Catarina Tavares

Member of

External Consultant of Cancer Signalling & Metabolism

Short CV

2009 Degree in Veterinary Medicine. Instituto de Ciências Biomédicas de Abel Salazar, University of Porto;

2009-2010 Small animal clinical practice;

2010-2011 Internship at the Laboratory of Veterinary Pathology and Immunology:
study of canine mammary tumors. Instituto de Ciências Biomédicas de Abel Salazar, University of Porto;

2/4/2011-30/4/2012 Research trainee. Project: "" Portuguese Wild Mushrooms: chemical characterization and functional study of antiproliferative and proapoptotic properties in cancer cell lines"". Ipatimup;

1/6/2012-29/3/2013 Research trainee. Project: “Transcriptional and post-transcriptional mechanisms of LRP1B inactivation in sporadic and familial non-medullary thyroid cancer”. Ipatimup;

1/4/13-3/4/17 PhD student. Project: Sodium/Iodide symporter restoration in thyroid tumors: overcoming therapy resistance. Ipatimup/Faculdade de Medicina, University of Porto.

Highlights

Endocrine neoplasias
Translational Research

PI (closed)

Estudo das possíveis interações entre a mutação BRAFV600E e a via do mTOR em carcinomas papilares da tiroide: potenciais consequências no comportamento tumoral e na resposta à terapia

First Author

1. Tavares C, Coelho MJ, Eloy C, Melo M, da Rocha AG, Pestana A, Batista R, Ferreira LB, Rios E, Selmi-Ruby S, Cavadas B, Pereira L, Sobrinho Simões M, Soares P

NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features. Endocrine connections 7: 78-90, 2018. [Article]

doi: 10.1530/EC-17-0302 PMID: 29298843.

3.0 (*)

2. Tavares C, Eloy C, Melo M, Gaspar da Rocha A, Pestana A, Batista R, Bueno Ferreira L, Rios E, Sobrinho Simões M, Soares P

mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression. International journal of molecular sciences 19: ., 2018. [Article]

doi: 10.3390/ijms19051448 PMID: 29757257.

3.7 (*)

3. Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M

ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome. European journal of endocrinology 174: R117-26, 2016. [Review]

doi: 10.1530/EJE-15-0605 PMID: 26510840.

4.1

4. Tavares C, Coelho MJ, Melo M, da Rocha AG, Pestana A, Batista R, Salgado C, Eloy C, Ferreira L, Rios E, Sobrinho-Simões M, Soares P

pmTOR is a marker of aggressiveness in papillary thyroid carcinomas. Surgery 160: 1582-1590, 2016. [Article]

doi: 10.1016/j.surg.2016.06.050 PMID: 27574774.

3.9

5. Tavares C, de Oliveira JT, Lopes C, Carvalheira J, Matos AJ, Rutteman G, Reis CA, Gärtner F

Mucin 6 and tn antigen expression in canine mammary tumours: correlation with pathological features. Journal of comparative pathology 147: 410-8, 2012. [Article]

doi: 10.1016/j.jcpa.2012.03.007 PMID: 22595635.

1.4

@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto